Not logged in? You're viewing the Free tier. Join for free or log in to access your membership content.
Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.
Disclosure: The author holds a long position in BWXT.
← Back to Free Index

BWXT

Analysis as of: 2026-02-05
BWX Technologies, Inc.
BWXT manufactures nuclear components and fuel and provides nuclear services for U.S. government, commercial nuclear, and medical customers.
aerospace defense energy healthcare nuclear
Jump to: SummaryAnalysisOpportunityRiskTrendsThird Party Analyst Consensus

Summary

Nuclear backlog conversion with enrichment optionality
Multi-year Navy/NNSA visibility anchors growth, while enrichment, services, and verification software can expand the profit pool. The gating risks are nuclear permissioning, U.S. budget stop-starts, and a premium multiple that can mean-revert on any execution slip.

Analysis

Thesis
BWXT is a permissioned nuclear-industrial compounder: if it sustains Navy/NNSA delivery cadence with clean compliance, enrichment/advanced fuels plus higher-value services can grow revenue faster than defense-industrial norms while defending a scarcity valuation via trust/verification and outcome-priced uptime.
Last Economy Alignment
Positive: the Last Economy rewards regulated trust, supply-chain sovereignty, and security—BWXT sells contracted, nuclear-qualified capacity with high switching costs; AI mainly boosts throughput/QA rather than commoditizing the product.
Upgrade to Allocator to also access: Thesis Critique

Opportunity Outlook

Average Implied 5-Year Multiple
1.9x (from 5 most recent analyses)
Reasoning
BWXT can preserve a premium multiple if it keeps converting Navy/NNSA backlog into on-time deliveries and cash, while scaling higher-trust adjacencies (enrichment task orders, lifecycle services via Kinectrics, and nuclear medicine). Recent enrichment and digital initiatives support a “verified delivery” narrative that defends pricing even as analytics labor cheapens.
Upgrade to Allocator to also access: Simplified Opportunity Explanation

Risk Assessment

Overall Risk Summary
The binders are (1) regulatory permissioning/compliance events that can halt throughput, (2) appropriations cadence delaying awards/task orders, (3) capex + working-capital swings during enrichment/services expansion, and (4) valuation risk: BWXT trades at a scarcity premium that can mean-revert on any miss.
Upgrade to Allocator to also access: Tech Maturity Risk Score, Adoption Timing Risk Score, Moat Strength Risk Score, Capital Needs Risk Score, Regulatory Risk Score, Execution Risk Score, Concentration Risk Score, Unit Economics Risk Score, Valuation Risk Score, Macro Sensitivity Risk Score

Third Party Analyst Consensus

12-Month Price Target
$199.20
Upgrade to Reader to also access: Bull Case, Base Case, Bear Case